These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8850383)

  • 41. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
    Brocard JJ; Keller U; Oberhänsli A; Riesen WF
    Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA; Spósito AC; Mansur AP; Solimene MC; Chamone D; da Luz PL; Pileggi F
    Arq Bras Cardiol; 1997 Apr; 68(4):257-60. PubMed ID: 9497506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II).
    Pietro DA; Alexander S; Mantell G; Staggers JE; Cook TJ
    Am J Cardiol; 1989 Mar; 63(11):682-6. PubMed ID: 2646895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
    Tamburrini LR
    Minerva Med; 1992 Jun; 83(6):347-53. PubMed ID: 1630695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
    Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia].
    Fricker J; Douste-Blazy P; Drouin P; De Gennes JL; Dachet C; Keller U
    Presse Med; 1990 Dec; 19(42):1927-30. PubMed ID: 2147752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
    Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
    J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.
    McDowell IF; Smye M; Trinick T; Shortt JA; Archibald MP; Trimble ER; Nicholls DP
    Br J Clin Pharmacol; 1991 Mar; 31(3):340-3. PubMed ID: 2054273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
    Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E; Truffert J; De Gennes JL
    Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
    Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of simvastatin on plasma lipids, lipoproteins and apoproteins (A1 and B). 24 cases of major primary hypercholesterolemia].
    Aubert I; Emmerich J; Charpak Y; Chanu B; Dachet C; Herlich D; Besseau M; Rouffy J; Jacotot B
    Presse Med; 1988 May; 17(18):901-4. PubMed ID: 2968595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statin therapy in clinical practice: new developments.
    Shepherd J
    Curr Opin Lipidol; 1995 Oct; 6(5):254-5. PubMed ID: 8520846
    [No Abstract]   [Full Text] [Related]  

  • 56. Dose-response of simvastatin in primary hypercholesterolemia.
    Tuomilehto J; Guimaraes AC; Kettner H; Lithell H; Pitkänen M; Sailer D; Van Gaal LF
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):941-9. PubMed ID: 7898078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Worldwide experience with simvastatin/lovastatin.
    Walker JF
    Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin.
    Stalenhoef AF; Stuyt PM; de Graaf J
    Neth J Med; 1997 Jul; 51(1):10-5. PubMed ID: 9260485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    Mölgaard J; von Schenck H; Olsson AG
    Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors.
    Bargossi AM; Grossi G; Fiorella PL; Gaddi A; Di Giulio R; Battino M
    Mol Aspects Med; 1994; 15 Suppl():s187-93. PubMed ID: 7752830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.